RxDoctor Payments Data

Jenna Dramise, PA

Surgical · Carson City, NVNPI 1083288104

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Johnson & Johnson at 34.1% of the total. 2025 is the largest year on record at $483, 4.7 times the $104 reported in 2023. That places this record below the midpoint for surgical clinicians in NV, where the typical reported total is $749.

$660in general payments, 2019–2025

Across 22 payments — averaging $30.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$225
  • Vertex$114
  • Cerapedics Inc.$93
  • Organogenesis Inc.$89
  • Smith+Nephew$45
  • Bioventus LLC$30
  • plus $65 from 3 others

What the payments were for

  • Food & beverage$660100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$660 in reported general payments places this provider in the 45th percentile of 91 surgical providers in Nevada.

See all surgical providers in Nevada

Medicare billing

Part B allowed, 2024
$22,896
Medicare patients
155
Services billed
390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin63$349
Oxycodone Hcl27$166
Methocarbamol14$58
Ondansetron Hcl13$16

Paid to pharmacies, not to this prescriber.

Other surgical in Carson City

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →